Item 8.01 Other Events.
On January 11, 2021, Harpoon Therapeutics, Inc. (the "Company") issued a press
release announcing the closing of its previously announced underwritten public
offering of 6,764,704 shares of its common stock, including 882,352 shares sold
pursuant to the exercise in full by the underwriters of their option to purchase
additional shares. The gross proceeds to the Company were approximately
$115.0 million, before deducting underwriting discounts, commissions and
offering expenses payable by the Company.
A copy of the Company's press release announcing the closing of the offering is
attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Press release dated January 11, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses